Lipe & Dalton’s Douglas Elliman DOUG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-120,469
Closed -$467K 103
2022
Q4
$467K Sell
120,469
-2,359
-2% -$9.41K 0.27% 61
2022
Q3
$480K Sell
122,828
-1,297
-1% -$6.41K 0.3% 59
2022
Q2
$566K Sell
124,125
-1,257
-1% -$6.96K 0.33% 59
2022
Q1
$872K Sell
125,382
-3,905
-3% -$29.6K 0.43% 53
2021
Q4
$1.42M Buy
+129,287
New +$1.45M 0.67% 42

Other funds holding DOUG

Lipe & Dalton's DOUG Position: Q1 2023 in Review

Lipe & Dalton sold out of Douglas Elliman (DOUG) in Q1 2023, closing a stake of 120,469 shares — an estimated $467K sold.

Lipe & Dalton first reported a position in DOUG in Q4 2021 and held it in 5 quarters. The position peaked at $1.42M in Q4 2021. 165 funds tracked by Wall St. Rank hold DOUG as of Q1 2023.

  • Lipe & Dalton reported no remaining Douglas Elliman position as of Q1 2023 after selling out during the quarter.
  • Lipe & Dalton sold 120,469 Douglas Elliman shares in Q1 2023, an estimated $467K.
  • Lipe & Dalton first reported a position in Douglas Elliman in Q4 2021 and held it in 5 quarters.
  • Lipe & Dalton's Douglas Elliman position peaked at $1.42M in Q4 2021.
  • 165 funds tracked by Wall St. Rank held Douglas Elliman as of Q1 2023.

Based on Lipe & Dalton's 13F filing for Q1 2023, filed 2 May 2023.